Rocket


Overview
Financials
News + Filings
Key Docs
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Omthera Pharmaceuticals, Inc. (OMTH)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-12Dec-31-11
   S-1/AS-1/A
Revenues  22.721.2
            Revenue growth  6.9% 
Cost of goods sold  22.721.2
Gross profit  0.00.0
            Gross margin  0.0%0.0%
Selling, general and administrative   [+]4.93.7
Other operating expenses  22.721.2
EBITDA   [+]-27.6-24.9
            EBITDA margin  -121.6%-117.5%
Depreciation and amortization  0.00.0
EBIT   [+]-27.6-24.9
            EBIT margin  -121.7%-117.6%
Interest expense   0.1
Other income (expense), net  0.00.1
Pre-tax income  -27.6-24.9
Income taxes  0.00.0
            Tax rate  0.0%0.0%
Net income  -27.6-24.9
            Net margin  -121.6%-117.6%
   
Basic EPS   [+]($14.41)($20.39)
Diluted EPS   [+]($14.41)($20.39)
   
Shares outstanding (basic)   [+]1.91.2
Shares outstanding (diluted)   [+]1.91.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy